AVBP
ArriVent BioPharma, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +7.7% ·
flujo de acciones +30.0% ·
nuevas posiciones netas +7.1%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | +6 | 17.31M | $600.66M | +10 | −4 |
| Q1 2026 | 63 | +7 | 15.17M | $349.66M | +10 | −3 |
| Q4 2025 | 56 | +3 | 14.51M | $292.04M | +3 | n/a |
| Q3 2025 | 14 | +1 | 10.75M | $198.25M | +2 | −1 |
| Q2 2025 | 10 | 0 | 7.02M | $152.80M | +2 | −2 |
| Q1 2025 | 7 | +1 | 1.69M | $31.28M | +2 | −1 |
| Q4 2024 | 6 | -1 | 1.52M | $40.62M | +1 | −2 |
| Q3 2024 | 6 | +4 | 925.82K | $21.76M | +4 | n/a |
| Q2 2024 | 2 | n/a | 247.05K | $4.58M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 3.41M | +65.6% | $62.87M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | BlackRock ✦ (pasivo) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ ×11 |
| 3 | The Vanguard Group ✦ (pasivo) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (pasivo) | 1.03M | +38.7% | $18.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 716.29K | +20.2% | $13.22M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Goldman Sachs Group ✦ | 431.94K | n/a | $7.97M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 392.02K | n/a | $7.23M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 8 | Millennium Management ✦ | 286.10K | +62.4% | $5.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Marshall Wace ✦ | 180.22K | Nuevo | $3.33M | 0.0% | New | 1 | SEC ↗ ×3 |
| 10 | Two Sigma Investments ✦ | 91.72K | Nuevo | $1.69M | 0.0% | New | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 12 | JPMorgan Chase ✦ | 27.98K | n/a | $516,268 | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 13 | T. Rowe Price ✦ | 14.36K | +25.3% | $265,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Marshall Wace | $3.33M | 0.0% |
| Two Sigma Investments | $1.69M | 0.0% |
Posición cerrada
| Citadel Advisors | $732,669 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 138 tenedores, 42.02M acciones, $965.37M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.